Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM6B | O15054 | 1/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | RECQL | P46063 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | HTR2A | P28223 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 2/20 | 0.44 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2029160 | 0.86 | KDM6B (0.72) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL5691448 | 0.84 | KDM6B (1.00) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL29869020 | 0.84 | KDM6B (1.00) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL29350434 | 0.84 | KDM6B (1.00) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL829784 | 0.84 | KDM6B (1.00) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL18469325 | 0.84 | KDM6B (1.00) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL12406009 | 0.83 | KDM6B (0.49) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL29085429 | 0.82 | KDM6B (0.96) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL29085430 | 0.82 | KDM6B (0.96) | KDM6BALOX15KDM4EHIF1AHSD17B10 | |
| SCHEMBL6535013 | 0.82 | KDM6B (0.96) | KDM6BALOX15KDM4EHIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | CARGILL, INCORPORATED (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | STT3A, SIGLEC7, STT3B | KDM6B 4245/4885ALOX15 4388/4885KDM4E 4391/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | KDM6B 2458/4885ALOX15 2972/4885KDM4E 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.